Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use

BACKGROUND AND AIMS: It is currently unclear whether sodium–glucose co-transporter 2 (SGLT2) inhibitor administration can improve the insulin sensitivity as well as rapidly reduce plasma glucose concentrations in humans during the early phase of treatment initiation. This study aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Yuka, Otsuka, Yoshie, Ashida, Kenji, Nagayama, Ayako, Hasuzawa, Nao, Iwata, Shimpei, Hara, Kento, Tsuruta, Munehisa, Wada, Nobuhiko, Motomura, Seiichi, Tajiri, Yuji, Nomura, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354734/
https://www.ncbi.nlm.nih.gov/pubmed/32580152
http://dx.doi.org/10.1530/EC-20-0082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354734/
https://www.ncbi.nlm.nih.gov/pubmed/32580152
http://dx.doi.org/10.1530/EC-20-0082

Ejemplares similares